Associating
genomic targets with human disease is a priority for new drug discovery.
A number of factors combine to make target and hypothesis validation efficient
in India. Chembiotek and its sister organizations, The Centre for Genomics
Applications, a core facility for genomics and ClinInvent, a clinical trials
CRO, have pooled their expertise and resource base to create clinical genomics
services that can be used to address client needs.
A number of founder populations Large family sizes Large patient loads across all common diseases Excellent hospitals with experienced clinicians State-of-the-art diagnostics. Competent histopathologists
SNP consortium of India – discovery and validation of SNPs Sequence based HLA typing of human hematopoetic stem cell repository Whole genome scans (10 cM) for LD study for a neurological disorder Microarray studies to identify blood expressed genes Recruitment, management of Phase III Clinical trial for a top-tier pharmaceutical firm Human whole blood assays for the evaluation of NCEs Analysis of FFPE blocks to look at gene expression in solid tumors
Large network of physicians for specific recruitment in desired therapeutic areas Association with large hospitals to source patient data and samples GCP based collection – informed consent, patient and family histories Clinical laboratory work up for tests of various kinds –biochemical, histological etc.
High Throughput Sequencing Service Whole Genome, Libraries & Genes Re-sequencing Sequence Based Identification Whole Genome Scans Custom Markers SNP Validation and Screening Custom Fragment Analysis Applications |
||||||||||